Treating Women with HIV: Is it Different than Treating Men?
- 13 April 2012
- journal article
- research article
- Published by Springer Nature in Current HIV/AIDS Reports
- Vol. 9 (2) , 171-178
Abstract
While antiretroviral therapy (ART) has had a tremendous impact on the morbidity and mortality of patients with HIV, there is evidence that many HIV-infected women experience treatment challenges that are different from men and these challenges are often associated with poorer outcomes. In the United States, blacks and Latino women are disproportionately affected by the HIV epidemic related to lack of access to high-quality HIV care, and socioeconomic factors. In Africa and Asia, HIV infection in women is affected by gender norms that often leave women dependent upon men (either emotionally or financially) and vulnerable in relationships. These gender norms and, in some cases, fears of violence make it difficult for women to refuse unprotected sex, and can contribute to higher infection rates in women and delayed entry to care. Many African migrants in Europe and Australia may feel stigmatized and fear discrimination when accessing care. As a consequence, despite the availability of highly active antiretroviral therapy, women with HIV often have delayed entry into care and experience poor outcomes. With the notable exception of treatment during pregnancy, there is little in the published literature to suggest that the treatment of choice for treatment-naïve patients should be determined by the patient’s sex. While virologic efficacy of ART may be similar in large clinical trials, differences in the frequency of treatment-related side effects and the impact of pregnancy and/or child-bearing status on treatment choice is well documented. In this paper we aim to discuss antiretroviral therapy in HIV-infected women, the sex-specific barriers to starting care, the differences in outcomes, and complications.Keywords
This publication has 58 references indexed in Scilit:
- Occupational stigma as a primary barrier to health care for street-based sex workers in CanadaCulture, Health & Sexuality, 2012
- Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During PregnancyThe Journal of Infectious Diseases, 2011
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011
- Effects of Darunavir/Ritonavir-Based Therapy on Metabolic and Anthropometric Parameters in Women and Men Over 48 WeeksAIDS Patient Care and STDs, 2011
- Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USAHIV Medicine, 2010
- Birth Defects Among Children Born to Human Immunodeficiency Virus-Infected WomenThe Pediatric Infectious Disease Journal, 2010
- Factors Associated with Mother‐to‐Child Transmission of HIV‐1 Despite a Maternal Viral Load <500 Copies/mL at Delivery: A Case‐Control Study Nested in the French Perinatal Cohort (EPF‐ANRS CO1)Clinical Infectious Diseases, 2010
- Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretroviralsAIDS, 2010
- Association of Child Care Burden and Household Composition with Adherence to Highly Active Antiretroviral Therapy in the Women's Interagency HIV StudyAIDS Patient Care and STDs, 2009
- Fat Distribution in Women With HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006